
Quick Heal Technologies Q4 FY26 Results: Loss Rs 20 Cr
Updated: 22 May 2026 • 10:39 am
Posted by:

Quick Heal Technologies Q4 FY26 results were declared on May 21, 2026. The company reported net loss of Rs 20 crore for the quarter ended March 31, 2026, down 566.7% YoY compared to loss of Rs 3 crore in Q4 FY25. Revenue from operations stood at Rs 49 crore. Results are on a Consolidated basis. Quick Heal Technologies is a Cybersecurity company listed on Indian stock exchanges.
Click Here – Get Free Investment Predictions
Quick Heal Technologies Q4 FY26 Financial Highlights
| Metric | Q4 FY26 (Rs Cr) | Q4 FY25 (Rs Cr) | YoY Change |
|---|---|---|---|
| Revenue | 49 | N/A | N/A |
| Net Loss | 20 | 3 | -566.7% |
| Basis | Consolidated | ||
Note: Quick Heal Technologies Q4 FY26 results declared May 21, 2026. Verify from BSE/NSE audited filings before investment decisions.
Quick Heal Technologies Q4 FY26 Performance Analysis
The Quick Heal Technologies Q4 FY26 results reflect the company’s operational performance in the January to March 2026 quarter. The quarter reflects near-term profitability challenges. Quick Heal Technologies operates in the Cybersecurity sector, which benefited from India’s GDP growth above 6.5% in FY26.
Revenue of Rs 49 crore reflects steady business conditions in the Cybersecurity sector.
Screen the best stocks on the Univest Screener.
Key Factors Driving Quick Heal Technologies Q4 FY26 Results
Revenue and Business Performance
Quick Heal Technologies Q4 FY26 revenue of Rs 49 crore was for the quarter ended March 31, 2026. Revenue momentum reflects steady demand in the Cybersecurity business.
Profitability and Margins
The business net loss of Rs 20 crore is down 566.7% YoY. Margin recovery and revenue growth will be the key operational levers entering FY27.
India Macro Backdrop
The January to March 2026 quarter benefited from India’s GDP growth above 6.5%, government capital expenditure of Rs 11.21 lakh crore for FY27, and resilient domestic consumption. RBI’s accommodative stance supported credit and demand conditions. The Cybersecurity sector saw strong tailwinds during this period.
FY27 Outlook
Following the firm results, management commentary on FY27 revenue guidance, margin expansion roadmap, and capital allocation will be key investor watchpoints. The Cybersecurity sector continues to benefit from India’s long-term structural growth.
Download the Univest iOS App or the Univest Android App to get daily stock recommendations and expert research.
Frequently Asked Questions on the company
What is Quick Heal Technologies Q4 FY26 net loss?
Ans. Quick Heal Technologies Q4 FY26 net loss of Rs 20 crore, down 566.7% YoY from loss of Rs 3 crore in Q4 FY25. Results declared May 21, 2026, on a Consolidated basis.
What is Quick Heal Technologies Q4 FY26 revenue?
Ans. Quick Heal Technologies Q4 FY26 revenue from operations was Rs 49 crore. Verify from BSE/NSE filings.
When were Quick Heal Technologies Q4 FY26 results declared?
Ans. Quick Heal Technologies Q4 FY26 results were declared on May 21, 2026, at the board of directors meeting approving audited Q4 and FY26 financial statements.
Is Quick Heal Technologies a good investment after Q4 FY26?
Ans. Investment decisions require individual assessment of fundamentals, valuation, and risk. This article is for educational purposes only. Consult a SEBI-registered financial advisor before investing.
Investments in securities are subject to market risk. This content is for educational purposes only. Verify all figures from BSE/NSE filings. Consult a SEBI-registered financial advisor.
Recent Articles
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Likhitha Infrastructure Analyst Review May 2026
Madhucon Projects Analyst Review May 2026
Laxmi India Finance Analyst Review May 2026
Kalyani Commercials Analyst Review May 2026
India Motor Parts and Accessories Analyst Review May 2026
Popular this week
Likhitha Infrastructure Analyst Review May 2026
Madhucon Projects Analyst Review May 2026
Laxmi India Finance Analyst Review May 2026
Kalyani Commercials Analyst Review May 2026
India Motor Parts and Accessories Analyst Review May 2026

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas





